Results 31 to 40 of about 2,265 (160)

Esomepraprole and levocetirizine market share. [PDF]

open access: yes, 2013
This figure shows changes in esomepraprole (A) and levocetirizine (B) market share before and after changes for these drugs in the HUG RDF and generics coming to market.
Christophe Combescure (146642)   +8 more
core   +1 more source

Comparative Efficacy and Safety of Ebastine 20 mg, Ebastine 10 mg and Levocetirizine 5 mg in Acute Urticaria [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Introduction: Acute and chronic urticaria can result in severely impaired quality of life from pruritus and associated sleep lessness, as well as anxiety and depression.
Vippan Goyal   +4 more
doaj   +1 more source

Evaluation of the Effect of Lactobacillus paracasei (HF.A00232) in Children (6–13 years old) with Perennial Allergic Rhinitis: A 12-week, Double-blind, Randomized, Placebo-controlled Study

open access: yesPediatrics and Neonatology, 2014
Dietary supplementation with probiotics alters intestinal microflora of children and may have immunomodulatory effects in prevention of allergic diseases. The aim of this study was to evaluate the effects of Lactobacillus paracasei (LP), strain HF.A00232,
Wen-Ya Lin   +4 more
doaj   +1 more source

Efficacy of Oral Bilastine in Comparison to Levocetirizine in Allergic RhinitisA Randomised Clinical Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Introduction: Allergic rhinitis is a heterogeneous disorder characterised by major symptoms like sneezing, itching, nasal congestion and rhinorrhea.
M VANITHA   +3 more
doaj   +1 more source

The modern view of treatment of allergic rhinitis and it’s combination with bronchial asthma

open access: yesМедицинский совет, 2021
In recent years, there has been a significant increase in the prevalence of diseases of the nose and paranasal sinuses. Inflammatory diseases of the mucous membrane nasal cavities (rhinitis) are most commonly characterized as a syndrome in which the ...
D. S. Smirnov, O. M. Kurbacheva
doaj   +1 more source

Long-term treatment of persistent allergic rhinitis with levocetirizine [PDF]

open access: yes, 2007
Background: The impact of treatment on specific aspects of health-related quality of life (HRQOL), including limitations in particular activities and quality of sleep, has not been clarified in persistent allergic rhinitis. Our objective was to determine
Van Cauwenberge, Paul   +6 more
core   +1 more source

Experience of Using Levocetirizine in Pediatric Practice [PDF]

open access: yes, 2014
The paper represents the latest views on antihistamine drugs use in pediatrics. For today, the most essential issue at acute and chronic allergic diseases in children is the use of new antihistamine drug ...
Yu.V. Marushko
core   +1 more source

Safety of levocetirizine treatment in young atopic children: an 18-month an 18-month study. [PDF]

open access: yes, 2007
There are more than 40 H-1-antihistamines available worldwide. Most of these medications have never been optimally studied in prospective, randomized, double-masked, placebo-controlled trials in children.
EPAAC Study Group: . . . M. Masi   +6 more
core   +1 more source

Levocetirizine-Loaded Electrospun Fibers from Water-Soluble Polymers: Encapsulation and Drug Release

open access: yesMolecules, 2023
Electrospun fibers containing levocetirizine, a BCS III drug, were prepared from three water-soluble polymers, hydroxypropyl methylcellulose (HPMC), polyvinylpyrrolidone (PVP) and polyvinyl alcohol (PVA).
Lan Yi   +4 more
doaj   +1 more source

Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors: Contribution of Lys191 and Thr194 [PDF]

open access: yes, 2002
Competition experiments with [3H]mepyramine showed that cetirizine and its enantiomers, levocetirizine and (S)-cetirizine, bound with high affinity and stereoselectivity to human H1 histamine receptors (Ki values of 6, 3, and 100 nM, respectively ...
Massingham, R   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy